European Active Surveillance Study of LCS12

Trial Profile

European Active Surveillance Study of LCS12

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Jan 2018

At a glance

  • Drugs Levonorgestrel (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Acronyms EURAS_LCS12
  • Most Recent Events

    • 25 Jan 2018 Planned End Date changed from 1 Jun 2021 to 1 Dec 2022.
    • 25 Jan 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Feb 2022.
    • 30 Aug 2017 Baseline characteristics results (n=26053, data cut off: Aug 2016) presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top